nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCB1—colon cancer	0.331	1	CbGaD
Pantoprazole—SLCO1B1—Irinotecan—colon cancer	0.0769	0.159	CbGbCtD
Pantoprazole—ABCG2—Irinotecan—colon cancer	0.0611	0.126	CbGbCtD
Pantoprazole—ABCG2—Fluorouracil—colon cancer	0.0587	0.121	CbGbCtD
Pantoprazole—ABCG2—Vincristine—colon cancer	0.0534	0.11	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—colon cancer	0.0407	0.0842	CbGbCtD
Pantoprazole—CYP2C9—Capecitabine—colon cancer	0.0368	0.076	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—colon cancer	0.0323	0.0669	CbGbCtD
Pantoprazole—CYP1A2—Fluorouracil—colon cancer	0.0242	0.05	CbGbCtD
Pantoprazole—ABCB1—Irinotecan—colon cancer	0.022	0.0456	CbGbCtD
Pantoprazole—CYP2C9—Fluorouracil—colon cancer	0.0218	0.0451	CbGbCtD
Pantoprazole—ABCB1—Vincristine—colon cancer	0.0193	0.0398	CbGbCtD
Pantoprazole—CYP3A4—Irinotecan—colon cancer	0.0132	0.0273	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—colon cancer	0.0117	0.0241	CbGbCtD
Pantoprazole—CYP3A4—Vincristine—colon cancer	0.0115	0.0239	CbGbCtD
Pantoprazole—ATP4B—digestive system—colon cancer	0.00316	0.149	CbGeAlD
Pantoprazole—ATP4B—liver—colon cancer	0.00235	0.111	CbGeAlD
Pantoprazole—ATP4A—epithelium—colon cancer	0.00181	0.0854	CbGeAlD
Pantoprazole—ATP4A—renal system—colon cancer	0.00168	0.0792	CbGeAlD
Pantoprazole—ATP4A—digestive system—colon cancer	0.00138	0.0649	CbGeAlD
Pantoprazole—ATP4A—liver—colon cancer	0.00102	0.0484	CbGeAlD
Pantoprazole—SLCO1B1—renal system—colon cancer	0.000899	0.0425	CbGeAlD
Pantoprazole—SLCO1B1—digestive system—colon cancer	0.000737	0.0348	CbGeAlD
Pantoprazole—SLCO1B1—liver—colon cancer	0.000549	0.0259	CbGeAlD
Pantoprazole—ABCB1—blood vessel—colon cancer	0.000543	0.0256	CbGeAlD
Pantoprazole—Omeprazole—ABCB1—colon cancer	0.000525	0.522	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—colon cancer	0.00048	0.478	CrCbGaD
Pantoprazole—CYP2C19—digestive system—colon cancer	0.00048	0.0227	CbGeAlD
Pantoprazole—CYP1A2—renal system—colon cancer	0.000478	0.0226	CbGeAlD
Pantoprazole—CYP2C19—vagina—colon cancer	0.000424	0.02	CbGeAlD
Pantoprazole—CYP1A2—digestive system—colon cancer	0.000392	0.0185	CbGeAlD
Pantoprazole—ABCG2—bone marrow—colon cancer	0.000376	0.0177	CbGeAlD
Pantoprazole—CYP2C9—digestive system—colon cancer	0.000372	0.0176	CbGeAlD
Pantoprazole—ABCG2—vagina—colon cancer	0.00036	0.017	CbGeAlD
Pantoprazole—CYP2C19—liver—colon cancer	0.000358	0.0169	CbGeAlD
Pantoprazole—CYP3A4—renal system—colon cancer	0.000346	0.0163	CbGeAlD
Pantoprazole—ABCB1—embryo—colon cancer	0.000324	0.0153	CbGeAlD
Pantoprazole—ABCG2—liver—colon cancer	0.000304	0.0143	CbGeAlD
Pantoprazole—CYP1A2—liver—colon cancer	0.000292	0.0138	CbGeAlD
Pantoprazole—CYP3A4—digestive system—colon cancer	0.000284	0.0134	CbGeAlD
Pantoprazole—CYP2C9—liver—colon cancer	0.000277	0.0131	CbGeAlD
Pantoprazole—ABCB1—epithelium—colon cancer	0.000264	0.0125	CbGeAlD
Pantoprazole—ABCB1—renal system—colon cancer	0.000245	0.0116	CbGeAlD
Pantoprazole—ABCG2—lymph node—colon cancer	0.000233	0.011	CbGeAlD
Pantoprazole—CYP3A4—liver—colon cancer	0.000212	0.00999	CbGeAlD
Pantoprazole—ABCB1—lymphoid tissue—colon cancer	0.000204	0.00961	CbGeAlD
Pantoprazole—ABCB1—digestive system—colon cancer	0.000201	0.00949	CbGeAlD
Pantoprazole—ABCB1—bone marrow—colon cancer	0.000185	0.00875	CbGeAlD
Pantoprazole—Nervous system disorder—Irinotecan—colon cancer	0.000183	0.00112	CcSEcCtD
Pantoprazole—Agranulocytosis—Capecitabine—colon cancer	0.000183	0.00112	CcSEcCtD
Pantoprazole—Thrombocytopenia—Irinotecan—colon cancer	0.000183	0.00112	CcSEcCtD
Pantoprazole—Anorexia—Vincristine—colon cancer	0.000183	0.00112	CcSEcCtD
Pantoprazole—Hyperhidrosis—Irinotecan—colon cancer	0.00018	0.00111	CcSEcCtD
Pantoprazole—Confusional state—Fluorouracil—colon cancer	0.00018	0.0011	CcSEcCtD
Pantoprazole—Mood swings—Methotrexate—colon cancer	0.000179	0.0011	CcSEcCtD
Pantoprazole—Hypotension—Vincristine—colon cancer	0.000179	0.0011	CcSEcCtD
Pantoprazole—Oedema—Fluorouracil—colon cancer	0.000179	0.00109	CcSEcCtD
Pantoprazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000179	0.00109	CcSEcCtD
Pantoprazole—Anorexia—Irinotecan—colon cancer	0.000178	0.00109	CcSEcCtD
Pantoprazole—Infection—Fluorouracil—colon cancer	0.000178	0.00109	CcSEcCtD
Pantoprazole—ABCB1—vagina—colon cancer	0.000178	0.00838	CbGeAlD
Pantoprazole—Haemoglobin—Capecitabine—colon cancer	0.000177	0.00108	CcSEcCtD
Pantoprazole—Rhinitis—Capecitabine—colon cancer	0.000176	0.00108	CcSEcCtD
Pantoprazole—Hepatitis—Capecitabine—colon cancer	0.000176	0.00108	CcSEcCtD
Pantoprazole—Haemorrhage—Capecitabine—colon cancer	0.000176	0.00108	CcSEcCtD
Pantoprazole—Nervous system disorder—Fluorouracil—colon cancer	0.000175	0.00107	CcSEcCtD
Pantoprazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000175	0.00107	CcSEcCtD
Pantoprazole—Hypoaesthesia—Capecitabine—colon cancer	0.000175	0.00107	CcSEcCtD
Pantoprazole—Liver function test abnormal—Methotrexate—colon cancer	0.000175	0.00107	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000175	0.00107	CcSEcCtD
Pantoprazole—Pharyngitis—Capecitabine—colon cancer	0.000174	0.00107	CcSEcCtD
Pantoprazole—Tachycardia—Fluorouracil—colon cancer	0.000174	0.00107	CcSEcCtD
Pantoprazole—Hypotension—Irinotecan—colon cancer	0.000174	0.00107	CcSEcCtD
Pantoprazole—Urinary tract disorder—Capecitabine—colon cancer	0.000174	0.00106	CcSEcCtD
Pantoprazole—Insomnia—Vincristine—colon cancer	0.000173	0.00106	CcSEcCtD
Pantoprazole—Oedema peripheral—Capecitabine—colon cancer	0.000173	0.00106	CcSEcCtD
Pantoprazole—Connective tissue disorder—Capecitabine—colon cancer	0.000173	0.00106	CcSEcCtD
Pantoprazole—Urethral disorder—Capecitabine—colon cancer	0.000172	0.00106	CcSEcCtD
Pantoprazole—Paraesthesia—Vincristine—colon cancer	0.000172	0.00105	CcSEcCtD
Pantoprazole—Breast disorder—Methotrexate—colon cancer	0.000171	0.00105	CcSEcCtD
Pantoprazole—Anorexia—Fluorouracil—colon cancer	0.00017	0.00104	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00017	0.00104	CcSEcCtD
Pantoprazole—Visual impairment—Capecitabine—colon cancer	0.000169	0.00104	CcSEcCtD
Pantoprazole—Insomnia—Irinotecan—colon cancer	0.000169	0.00103	CcSEcCtD
Pantoprazole—Paraesthesia—Irinotecan—colon cancer	0.000168	0.00103	CcSEcCtD
Pantoprazole—Hypotension—Fluorouracil—colon cancer	0.000167	0.00102	CcSEcCtD
Pantoprazole—Decreased appetite—Vincristine—colon cancer	0.000167	0.00102	CcSEcCtD
Pantoprazole—Dyspnoea—Irinotecan—colon cancer	0.000166	0.00102	CcSEcCtD
Pantoprazole—Erythema multiforme—Capecitabine—colon cancer	0.000166	0.00102	CcSEcCtD
Pantoprazole—Somnolence—Irinotecan—colon cancer	0.000166	0.00102	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000165	0.00101	CcSEcCtD
Pantoprazole—Fatigue—Vincristine—colon cancer	0.000165	0.00101	CcSEcCtD
Pantoprazole—Eye disorder—Capecitabine—colon cancer	0.000164	0.00101	CcSEcCtD
Pantoprazole—Dyspepsia—Irinotecan—colon cancer	0.000164	0.00101	CcSEcCtD
Pantoprazole—Tinnitus—Capecitabine—colon cancer	0.000164	0.001	CcSEcCtD
Pantoprazole—Pain—Vincristine—colon cancer	0.000164	0.001	CcSEcCtD
Pantoprazole—Constipation—Vincristine—colon cancer	0.000164	0.001	CcSEcCtD
Pantoprazole—Asthma—Methotrexate—colon cancer	0.000164	0.001	CcSEcCtD
Pantoprazole—Flushing—Capecitabine—colon cancer	0.000163	0.000999	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000163	0.000997	CcSEcCtD
Pantoprazole—Decreased appetite—Irinotecan—colon cancer	0.000162	0.000994	CcSEcCtD
Pantoprazole—Eosinophilia—Methotrexate—colon cancer	0.000162	0.000992	CcSEcCtD
Pantoprazole—Insomnia—Fluorouracil—colon cancer	0.000162	0.00099	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000161	0.000987	CcSEcCtD
Pantoprazole—Fatigue—Irinotecan—colon cancer	0.000161	0.000985	CcSEcCtD
Pantoprazole—Paraesthesia—Fluorouracil—colon cancer	0.000161	0.000983	CcSEcCtD
Pantoprazole—Pancreatitis—Methotrexate—colon cancer	0.00016	0.000982	CcSEcCtD
Pantoprazole—Pain—Irinotecan—colon cancer	0.00016	0.000977	CcSEcCtD
Pantoprazole—Constipation—Irinotecan—colon cancer	0.00016	0.000977	CcSEcCtD
Pantoprazole—Dyspnoea—Fluorouracil—colon cancer	0.000159	0.000976	CcSEcCtD
Pantoprazole—Somnolence—Fluorouracil—colon cancer	0.000159	0.000973	CcSEcCtD
Pantoprazole—Immune system disorder—Capecitabine—colon cancer	0.000159	0.000973	CcSEcCtD
Pantoprazole—Chills—Capecitabine—colon cancer	0.000158	0.000966	CcSEcCtD
Pantoprazole—Dyspepsia—Fluorouracil—colon cancer	0.000157	0.000964	CcSEcCtD
Pantoprazole—Arrhythmia—Capecitabine—colon cancer	0.000157	0.000962	CcSEcCtD
Pantoprazole—Abdominal discomfort—Methotrexate—colon cancer	0.000157	0.00096	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Vincristine—colon cancer	0.000157	0.00096	CcSEcCtD
Pantoprazole—Decreased appetite—Fluorouracil—colon cancer	0.000155	0.000952	CcSEcCtD
Pantoprazole—Alopecia—Capecitabine—colon cancer	0.000155	0.000952	CcSEcCtD
Pantoprazole—Pancytopenia—Methotrexate—colon cancer	0.000155	0.000951	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000154	0.000945	CcSEcCtD
Pantoprazole—Mental disorder—Capecitabine—colon cancer	0.000154	0.000943	CcSEcCtD
Pantoprazole—Feeling abnormal—Irinotecan—colon cancer	0.000154	0.000942	CcSEcCtD
Pantoprazole—Malnutrition—Capecitabine—colon cancer	0.000153	0.000937	CcSEcCtD
Pantoprazole—Dysuria—Methotrexate—colon cancer	0.000153	0.000936	CcSEcCtD
Pantoprazole—Pain—Fluorouracil—colon cancer	0.000153	0.000936	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000153	0.000935	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000152	0.000931	CcSEcCtD
Pantoprazole—Body temperature increased—Vincristine—colon cancer	0.000151	0.000928	CcSEcCtD
Pantoprazole—Abdominal pain—Vincristine—colon cancer	0.000151	0.000928	CcSEcCtD
Pantoprazole—Flatulence—Capecitabine—colon cancer	0.000151	0.000924	CcSEcCtD
Pantoprazole—Erectile dysfunction—Methotrexate—colon cancer	0.000151	0.000922	CcSEcCtD
Pantoprazole—Dysgeusia—Capecitabine—colon cancer	0.00015	0.000918	CcSEcCtD
Pantoprazole—ABCB1—liver—colon cancer	0.00015	0.00707	CbGeAlD
Pantoprazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000149	0.000914	CcSEcCtD
Pantoprazole—Back pain—Capecitabine—colon cancer	0.000148	0.000907	CcSEcCtD
Pantoprazole—Abdominal pain—Irinotecan—colon cancer	0.000148	0.000904	CcSEcCtD
Pantoprazole—Body temperature increased—Irinotecan—colon cancer	0.000148	0.000904	CcSEcCtD
Pantoprazole—Feeling abnormal—Fluorouracil—colon cancer	0.000147	0.000902	CcSEcCtD
Pantoprazole—Muscle spasms—Capecitabine—colon cancer	0.000147	0.000901	CcSEcCtD
Pantoprazole—Pneumonia—Methotrexate—colon cancer	0.000147	0.000898	CcSEcCtD
Pantoprazole—Infestation NOS—Methotrexate—colon cancer	0.000146	0.000893	CcSEcCtD
Pantoprazole—Infestation—Methotrexate—colon cancer	0.000146	0.000893	CcSEcCtD
Pantoprazole—Depression—Methotrexate—colon cancer	0.000145	0.00089	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000145	0.000885	CcSEcCtD
Pantoprazole—Vision blurred—Capecitabine—colon cancer	0.000144	0.000883	CcSEcCtD
Pantoprazole—Tremor—Capecitabine—colon cancer	0.000143	0.000878	CcSEcCtD
Pantoprazole—Stomatitis—Methotrexate—colon cancer	0.000142	0.00087	CcSEcCtD
Pantoprazole—Ill-defined disorder—Capecitabine—colon cancer	0.000142	0.00087	CcSEcCtD
Pantoprazole—Urticaria—Fluorouracil—colon cancer	0.000142	0.00087	CcSEcCtD
Pantoprazole—Conjunctivitis—Methotrexate—colon cancer	0.000142	0.000868	CcSEcCtD
Pantoprazole—Anaemia—Capecitabine—colon cancer	0.000141	0.000866	CcSEcCtD
Pantoprazole—Body temperature increased—Fluorouracil—colon cancer	0.000141	0.000865	CcSEcCtD
Pantoprazole—Hypersensitivity—Vincristine—colon cancer	0.000141	0.000865	CcSEcCtD
Pantoprazole—Sweating—Methotrexate—colon cancer	0.00014	0.000856	CcSEcCtD
Pantoprazole—Haematuria—Methotrexate—colon cancer	0.000139	0.000851	CcSEcCtD
Pantoprazole—Malaise—Capecitabine—colon cancer	0.000138	0.000845	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000138	0.000845	CcSEcCtD
Pantoprazole—Epistaxis—Methotrexate—colon cancer	0.000138	0.000842	CcSEcCtD
Pantoprazole—Vertigo—Capecitabine—colon cancer	0.000138	0.000842	CcSEcCtD
Pantoprazole—Hypersensitivity—Irinotecan—colon cancer	0.000137	0.000842	CcSEcCtD
Pantoprazole—Asthenia—Vincristine—colon cancer	0.000137	0.000842	CcSEcCtD
Pantoprazole—Syncope—Capecitabine—colon cancer	0.000137	0.000841	CcSEcCtD
Pantoprazole—Leukopenia—Capecitabine—colon cancer	0.000137	0.000839	CcSEcCtD
Pantoprazole—Agranulocytosis—Methotrexate—colon cancer	0.000136	0.000833	CcSEcCtD
Pantoprazole—Palpitations—Capecitabine—colon cancer	0.000135	0.000828	CcSEcCtD
Pantoprazole—Loss of consciousness—Capecitabine—colon cancer	0.000135	0.000824	CcSEcCtD
Pantoprazole—Asthenia—Irinotecan—colon cancer	0.000134	0.00082	CcSEcCtD
Pantoprazole—Cough—Capecitabine—colon cancer	0.000134	0.000818	CcSEcCtD
Pantoprazole—Hypertension—Capecitabine—colon cancer	0.000132	0.000809	CcSEcCtD
Pantoprazole—Hypersensitivity—Fluorouracil—colon cancer	0.000132	0.000807	CcSEcCtD
Pantoprazole—Haemoglobin—Methotrexate—colon cancer	0.000132	0.000806	CcSEcCtD
Pantoprazole—Diarrhoea—Vincristine—colon cancer	0.000131	0.000803	CcSEcCtD
Pantoprazole—Haemorrhage—Methotrexate—colon cancer	0.000131	0.000802	CcSEcCtD
Pantoprazole—Hepatitis—Methotrexate—colon cancer	0.000131	0.000802	CcSEcCtD
Pantoprazole—Chest pain—Capecitabine—colon cancer	0.00013	0.000798	CcSEcCtD
Pantoprazole—Arthralgia—Capecitabine—colon cancer	0.00013	0.000798	CcSEcCtD
Pantoprazole—Myalgia—Capecitabine—colon cancer	0.00013	0.000798	CcSEcCtD
Pantoprazole—Pharyngitis—Methotrexate—colon cancer	0.00013	0.000796	CcSEcCtD
Pantoprazole—Anxiety—Capecitabine—colon cancer	0.00013	0.000795	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000129	0.000793	CcSEcCtD
Pantoprazole—Urinary tract disorder—Methotrexate—colon cancer	0.000129	0.000792	CcSEcCtD
Pantoprazole—Discomfort—Capecitabine—colon cancer	0.000129	0.000788	CcSEcCtD
Pantoprazole—Urethral disorder—Methotrexate—colon cancer	0.000128	0.000786	CcSEcCtD
Pantoprazole—Diarrhoea—Irinotecan—colon cancer	0.000128	0.000782	CcSEcCtD
Pantoprazole—Dry mouth—Capecitabine—colon cancer	0.000127	0.00078	CcSEcCtD
Pantoprazole—Dizziness—Vincristine—colon cancer	0.000127	0.000776	CcSEcCtD
Pantoprazole—Pruritus—Fluorouracil—colon cancer	0.000126	0.000775	CcSEcCtD
Pantoprazole—Visual impairment—Methotrexate—colon cancer	0.000126	0.000773	CcSEcCtD
Pantoprazole—Confusional state—Capecitabine—colon cancer	0.000126	0.000771	CcSEcCtD
Pantoprazole—Oedema—Capecitabine—colon cancer	0.000125	0.000765	CcSEcCtD
Pantoprazole—Infection—Capecitabine—colon cancer	0.000124	0.00076	CcSEcCtD
Pantoprazole—Erythema multiforme—Methotrexate—colon cancer	0.000124	0.000758	CcSEcCtD
Pantoprazole—Dizziness—Irinotecan—colon cancer	0.000123	0.000756	CcSEcCtD
Pantoprazole—Shock—Capecitabine—colon cancer	0.000123	0.000753	CcSEcCtD
Pantoprazole—Nervous system disorder—Capecitabine—colon cancer	0.000122	0.00075	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—colon cancer	0.000122	0.000749	CcSEcCtD
Pantoprazole—Diarrhoea—Fluorouracil—colon cancer	0.000122	0.000749	CcSEcCtD
Pantoprazole—Thrombocytopenia—Capecitabine—colon cancer	0.000122	0.000749	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—colon cancer	0.000122	0.000747	CcSEcCtD
Pantoprazole—Tachycardia—Capecitabine—colon cancer	0.000122	0.000747	CcSEcCtD
Pantoprazole—Vomiting—Vincristine—colon cancer	0.000122	0.000746	CcSEcCtD
Pantoprazole—Skin disorder—Capecitabine—colon cancer	0.000121	0.000743	CcSEcCtD
Pantoprazole—Rash—Vincristine—colon cancer	0.000121	0.00074	CcSEcCtD
Pantoprazole—Hyperhidrosis—Capecitabine—colon cancer	0.000121	0.00074	CcSEcCtD
Pantoprazole—Dermatitis—Vincristine—colon cancer	0.000121	0.000739	CcSEcCtD
Pantoprazole—Headache—Vincristine—colon cancer	0.00012	0.000735	CcSEcCtD
Pantoprazole—Anorexia—Capecitabine—colon cancer	0.000119	0.000729	CcSEcCtD
Pantoprazole—Vomiting—Irinotecan—colon cancer	0.000119	0.000727	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—colon cancer	0.000118	0.000724	CcSEcCtD
Pantoprazole—Dizziness—Fluorouracil—colon cancer	0.000118	0.000724	CcSEcCtD
Pantoprazole—Rash—Irinotecan—colon cancer	0.000118	0.000721	CcSEcCtD
Pantoprazole—Dermatitis—Irinotecan—colon cancer	0.000118	0.00072	CcSEcCtD
Pantoprazole—Chills—Methotrexate—colon cancer	0.000117	0.000719	CcSEcCtD
Pantoprazole—Headache—Irinotecan—colon cancer	0.000117	0.000716	CcSEcCtD
Pantoprazole—Hypotension—Capecitabine—colon cancer	0.000117	0.000715	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—colon cancer	0.000116	0.000708	CcSEcCtD
Pantoprazole—ABCB1—lymph node—colon cancer	0.000115	0.00542	CbGeAlD
Pantoprazole—Mental disorder—Methotrexate—colon cancer	0.000115	0.000702	CcSEcCtD
Pantoprazole—Malnutrition—Methotrexate—colon cancer	0.000114	0.000698	CcSEcCtD
Pantoprazole—Nausea—Vincristine—colon cancer	0.000114	0.000697	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000114	0.000697	CcSEcCtD
Pantoprazole—Vomiting—Fluorouracil—colon cancer	0.000114	0.000696	CcSEcCtD
Pantoprazole—Insomnia—Capecitabine—colon cancer	0.000113	0.000692	CcSEcCtD
Pantoprazole—Rash—Fluorouracil—colon cancer	0.000113	0.00069	CcSEcCtD
Pantoprazole—Dermatitis—Fluorouracil—colon cancer	0.000113	0.00069	CcSEcCtD
Pantoprazole—Paraesthesia—Capecitabine—colon cancer	0.000112	0.000687	CcSEcCtD
Pantoprazole—Headache—Fluorouracil—colon cancer	0.000112	0.000686	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—colon cancer	0.000112	0.000683	CcSEcCtD
Pantoprazole—Dyspnoea—Capecitabine—colon cancer	0.000111	0.000682	CcSEcCtD
Pantoprazole—Nausea—Irinotecan—colon cancer	0.000111	0.000679	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—colon cancer	0.00011	0.000675	CcSEcCtD
Pantoprazole—Dyspepsia—Capecitabine—colon cancer	0.00011	0.000673	CcSEcCtD
Pantoprazole—Decreased appetite—Capecitabine—colon cancer	0.000109	0.000665	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000108	0.00066	CcSEcCtD
Pantoprazole—Fatigue—Capecitabine—colon cancer	0.000108	0.00066	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—colon cancer	0.000107	0.000658	CcSEcCtD
Pantoprazole—Constipation—Capecitabine—colon cancer	0.000107	0.000654	CcSEcCtD
Pantoprazole—Pain—Capecitabine—colon cancer	0.000107	0.000654	CcSEcCtD
Pantoprazole—Nausea—Fluorouracil—colon cancer	0.000106	0.00065	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—colon cancer	0.000106	0.000647	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—colon cancer	0.000105	0.000645	CcSEcCtD
Pantoprazole—Feeling abnormal—Capecitabine—colon cancer	0.000103	0.00063	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—colon cancer	0.000103	0.000629	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—colon cancer	0.000102	0.000627	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000102	0.000626	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—colon cancer	0.000102	0.000625	CcSEcCtD
Pantoprazole—Cough—Methotrexate—colon cancer	9.94e-05	0.000609	CcSEcCtD
Pantoprazole—Urticaria—Capecitabine—colon cancer	9.92e-05	0.000608	CcSEcCtD
Pantoprazole—Abdominal pain—Capecitabine—colon cancer	9.87e-05	0.000605	CcSEcCtD
Pantoprazole—Body temperature increased—Capecitabine—colon cancer	9.87e-05	0.000605	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—colon cancer	9.87e-05	0.000605	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—colon cancer	9.7e-05	0.000594	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—colon cancer	9.7e-05	0.000594	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—colon cancer	9.7e-05	0.000594	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.63e-05	0.00059	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—colon cancer	9.58e-05	0.000587	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—colon cancer	9.38e-05	0.000574	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—colon cancer	9.3e-05	0.00057	CcSEcCtD
Pantoprazole—Infection—Methotrexate—colon cancer	9.24e-05	0.000566	CcSEcCtD
Pantoprazole—Hypersensitivity—Capecitabine—colon cancer	9.2e-05	0.000564	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—colon cancer	9.12e-05	0.000559	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—colon cancer	9.1e-05	0.000558	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—colon cancer	9.03e-05	0.000553	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—colon cancer	8.99e-05	0.000551	CcSEcCtD
Pantoprazole—Asthenia—Capecitabine—colon cancer	8.96e-05	0.000549	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—colon cancer	8.86e-05	0.000543	CcSEcCtD
Pantoprazole—Pruritus—Capecitabine—colon cancer	8.84e-05	0.000541	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—colon cancer	8.69e-05	0.000532	CcSEcCtD
Pantoprazole—Diarrhoea—Capecitabine—colon cancer	8.55e-05	0.000523	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—colon cancer	8.47e-05	0.000519	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—colon cancer	8.41e-05	0.000515	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—colon cancer	8.35e-05	0.000511	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—colon cancer	8.29e-05	0.000508	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—colon cancer	8.27e-05	0.000506	CcSEcCtD
Pantoprazole—Dizziness—Capecitabine—colon cancer	8.26e-05	0.000506	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—colon cancer	8.18e-05	0.000501	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—colon cancer	8.08e-05	0.000495	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—colon cancer	8.03e-05	0.000492	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—colon cancer	8.02e-05	0.000491	CcSEcCtD
Pantoprazole—Pain—Methotrexate—colon cancer	7.95e-05	0.000487	CcSEcCtD
Pantoprazole—Vomiting—Capecitabine—colon cancer	7.94e-05	0.000486	CcSEcCtD
Pantoprazole—Rash—Capecitabine—colon cancer	7.88e-05	0.000482	CcSEcCtD
Pantoprazole—Dermatitis—Capecitabine—colon cancer	7.87e-05	0.000482	CcSEcCtD
Pantoprazole—Headache—Capecitabine—colon cancer	7.82e-05	0.000479	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—colon cancer	7.66e-05	0.000469	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—colon cancer	7.6e-05	0.000466	CcSEcCtD
Pantoprazole—Nausea—Capecitabine—colon cancer	7.42e-05	0.000454	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—colon cancer	7.39e-05	0.000452	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—colon cancer	7.35e-05	0.00045	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—colon cancer	7.35e-05	0.00045	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—colon cancer	6.85e-05	0.00042	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—colon cancer	6.67e-05	0.000409	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—colon cancer	6.58e-05	0.000403	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—colon cancer	6.36e-05	0.00039	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—colon cancer	6.15e-05	0.000377	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—colon cancer	5.91e-05	0.000362	CcSEcCtD
Pantoprazole—Rash—Methotrexate—colon cancer	5.86e-05	0.000359	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—colon cancer	5.86e-05	0.000359	CcSEcCtD
Pantoprazole—Headache—Methotrexate—colon cancer	5.83e-05	0.000357	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—colon cancer	5.52e-05	0.000338	CcSEcCtD
